NeoPharm, Pharmacia & Upjohn deal

NEO received a $2 million payment from Pharmacia & Upjohn for an undisclosed milestone under the companies' February agreement to develop and market NEO's Liposomal Encapsulated Paclitaxel (LEP) and L...